Norgestimate/Ethinyl Estradiol Tablets
SPE2D2-25-D-0009 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Villaquilambre. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
SPE2D2-25-D-0009 P00001 to exercise Option Year 1 effective April 27, 2026 through April 26, 2027. SPE2D2-25-D-0009 Norgestimate/Ethinyl Estradiol Tablets Award
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
Questions
What is solicitation SPE2D2-25-D-0009?
Norgestimate/Ethinyl Estradiol Tablets, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING), performed in Villaquilambre.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.